Related references
Note: Only part of the references are listed.Turning chiral peptides into a racemic supraparticle to induce the self-degradation of MDM2
Wenguang Yang et al.
JOURNAL OF ADVANCED RESEARCH (2023)
Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics
Shuchan Li et al.
CELL BIOLOGY AND TOXICOLOGY (2022)
Human mesenchymal stem cells
Xiaoyong Chen et al.
CELL PROLIFERATION (2022)
Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapy
Wangxiao He et al.
THERANOSTICS (2022)
A Bionic-Homodimerization Strategy for Optimizing Modulators of Protein-Protein Interactions: From Statistical Mechanics Theory to Potential Clinical Translation
Jin Yan et al.
ADVANCED SCIENCE (2022)
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma
Aimin Jiang et al.
FRONTIERS IN GENETICS (2022)
PD-1/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis
Youliang Zhao et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosis
Katharina Heinzelmann et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis
Abhalaxmi Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways
Xia Guo et al.
SCIENTIFIC REPORTS (2022)
Single-Cell RNA Sequencing Reveals the Interaction of Injected ADSCs with Lung-Originated Cells in Mouse Pulmonary Fibrosis
Mamatali Rahman et al.
STEM CELLS INTERNATIONAL (2022)
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Jincheng Wang et al.
ACTA PHARMACEUTICA SINICA B (2022)
Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology
Tuan Hiep Tran et al.
ROYAL SOCIETY OPEN SCIENCE (2022)
Cell-Surface Programmed Death Ligand-1 Expression Identifies a Sub-Population of Distal Epithelial Cells Enriched in Idiopathic Pulmonary Fibrosis
Negah Ahmadvand et al.
CELLS (2022)
Lung microbiome and transcriptome reveal mechanisms underlying PM2.5 induced pulmonary fibrosis
Qiyue Jia et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2022)
Developmentally engineered bio-assemblies releasing neurotrophic exosomes guide in situ neuroplasticity following spinal cord injury
Jin Yan et al.
MATERIALS TODAY BIO (2022)
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
Rodney Cheng-En Hsieh et al.
SCIENCE IMMUNOLOGY (2022)
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Wenxian Wang et al.
THORACIC CANCER (2022)
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity
Yan Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Immune dysregulation as a driver of idiopathic pulmonary fibrosis
Kevin Shenderov et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Adam D. Cotton et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis
Dong Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?
Sara Lettieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice
Jing Qu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Challenges and advances in clinical applications of mesenchymal stromal cells
Tian Zhou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Macrophage autophagy protects mice from cerium oxide nanoparticle-induced lung fibrosis
Balasubramanyam Annangi et al.
PARTICLE AND FIBRE TOXICOLOGY (2021)
Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma
Aimin Jiang et al.
JOURNAL OF THORACIC DISEASE (2021)
Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
Shengnan Yang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Role and mechanisms of autophagy in lung metabolism and repair
Xue Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
Shih-Hsun Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis
Sissel Kronborg-White et al.
JOURNAL OF CLINICAL MEDICINE (2021)
De Novo Nano-Erythrocyte Structurally Braced by Biomimetic Au(I)-peptide Skeleton for MDM2/MDMX Predation toward Augmented Pulmonary Adenocarcinoma Immunotherapy
Xiaoqiang Zheng et al.
SMALL (2021)
Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients
Ho Cheol Kim et al.
SCIENTIFIC REPORTS (2021)
Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
Eleanor Valenzi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Selective Degradation of PD-L1 in Cancer Cells by Enzyme-Instructed Self-Assembly
Yuhan Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis
Yoshio Nakahara et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis
Shan-Shan Liu et al.
IMMUNITY (2021)
Autophagy, Apoptosis, the Unfolded Protein Response, and Lung Function in Idiopathic Pulmonary Fibrosis
Pawan Sharma et al.
CELLS (2021)
Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment
I-Ying Kuo et al.
THERANOSTICS (2021)
A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity
Siqi Yan et al.
THERANOSTICS (2021)
Regulation of sister chromatid cohesion by nuclear PD-L1
Jia Yu et al.
CELL RESEARCH (2020)
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
Taylor S. Adams et al.
SCIENCE ADVANCES (2020)
Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis
Arun C. Habermann et al.
SCIENCE ADVANCES (2020)
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Qingyang Lei et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction
Jin Yan et al.
NANO LETTERS (2020)
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
Wendan Yu et al.
CELL DEATH & DISEASE (2020)
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Yang Gao et al.
NATURE CELL BIOLOGY (2020)
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
Caterina Costa et al.
CELL DEATH & DISEASE (2020)
De novo supraparticle construction by a self-assembled Janus cyclopeptide to tame hydrophilic microRNA and hydrophobic molecule for anti-tumor cocktail therapy and augmented immunity
Junjun She et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice
Ae Rin Baek et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
A general-purpose Nanohybrid fabricated by Polymeric Au(I)-peptide precursor to wake the function of Peptide Therapeutics
Jin Yan et al.
THERANOSTICS (2020)
Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles
Daping Yang et al.
IMMUNITY (2019)
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Xiaojuan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Single-cell RNA sequencing profiling of the effects of aging on alveolar stem cells
Tingting Lv et al.
SCIENCE CHINA-LIFE SCIENCES (2019)
The clinical significance of soluble PD-1 and PD-L1 in lung cancer
Taher Abu Hejleh et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
JanWillem Duitman et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis
Yu Jing-Ze et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis
Paul A. Reyfman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
Dvir Aran et al.
NATURE IMMUNOLOGY (2019)
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway
K. Kondo et al.
LEUKEMIA (2018)
Self-Assembled Peptide-Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery
Jin Yan et al.
ACS NANO (2018)
The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFN-γ-producing γδT cells in mice
Remo C. Russo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice
Ke Ni et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Deletion of c-FLIP from CD11b(hi) Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis
Alexandra L. McCubbrey et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux
Kui Wang et al.
AUTOPHAGY (2018)
Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy
Fan Niu et al.
BIOMATERIALS (2018)
When worlds collide: Th17 and Treg cells in cancer and autoimmunity
Hannah M. Knochelmann et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer
Yusuke Okuma et al.
CLINICAL LUNG CANCER (2018)
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
Jessica Lawrence et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Metformin reverses established lung fibrosis in a bleomycin model
Sunad Rangarajan et al.
NATURE MEDICINE (2018)
Impact of Treg on other T cell subsets in progression of fibrosis in experimental lung fibrosis
Kaustav Chakraborty et al.
TISSUE & CELL (2018)
Expression of Programmed Death-Ligand 1 by Human Colonic CD90(+) Stromal Cells Differs Betweem Ulcerative Colitis and Crohn's Disease and Determines Their Capacity to Suppress Th1 Cells
Ellen J. Beswick et al.
FRONTIERS IN IMMUNOLOGY (2018)
Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch
Wangxiao He et al.
CHEMISTRY OF MATERIALS (2018)
Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study
Dragana Jovanovic et al.
JOURNAL OF THORACIC DISEASE (2018)
Soluble immune checkpoints in cancer: production, function and biological significance
Daqian Gu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery
Zhenyuan Bian et al.
THERANOSTICS (2018)
IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis
Ellyse Cipolla et al.
FASEB JOURNAL (2017)
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Alexander V. Misharin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease
Alexandra Paun et al.
SCIENTIFIC REPORTS (2017)
Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis
Ziliang Hou et al.
RESPIRATORY RESEARCH (2017)
p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis
Shwetha K. Shetty et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation
Lindsay J. Celada et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Regulatory T Cells in Idiopathic Pulmonary Fibrosis Too Much of a Good Thing?
Meagan W. Moore et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis
Isis E. Fernandez et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib
Steffen Filskov Sorensen et al.
LUNG CANCER (2016)
INFLAMMATORY DISEASE T cell-targeted antibody reverses fibrosis
Sarah Crunkhorn
NATURE REVIEWS DRUG DISCOVERY (2016)
Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
Yan Xu et al.
JCI INSIGHT (2016)
Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGF1
Meredith L. Sosulski et al.
AGING CELL (2015)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis
Sandra Cabrera et al.
AUTOPHAGY (2015)
The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
Sara Tomassetti et al.
CHEST (2015)
Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance
Shanshan Xiong et al.
IMMUNOBIOLOGY (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN- γ - secreting T-cell Ratios in Bleomycin-treated Mice
Keunhee Oh et al.
IMMUNE NETWORK (2015)
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
Jie Liu et al.
PLOS ONE (2015)
Future Directions in Idiopathic Pulmonary Fibrosis Research
Timothy S. Blackwell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Blockade of the Programmed Death-1 Pathway Restores Sarcoidosis CD4+ T-Cell Proliferative Capacity
Nicole A. Braun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
A Complex between Atg7 and Caspase-9 A NOVEL MECHANISM OF CROSS-REGULATION BETWEEN AUTOPHAGY AND APOPTOSIS
Jie Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis
Thanh-Thuy T. Le et al.
JOURNAL OF IMMUNOLOGY (2014)
TLR4 Activation Enhances the PD-L1-Mediated Tolerogenic Capacity of Colonic CD90+ Stromal Cells
Ellen J. Beswick et al.
JOURNAL OF IMMUNOLOGY (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice
Ying Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
Insufficient autophagy in idiopathic pulmonary fibrosis
Jun Araya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment
R. W. J. Meijers et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
Jose D. Herazo-Maya et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Hypermethylation-mediated silencing of p14ARF in fibroblasts from idiopathic pulmonary fibrosis
Jose Cisneros et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system
Yashodhar P. Bhandary et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Regulation of Airway and Alveolar Epithelial Cell Apoptosis by p53-Induced Plasminogen Activator Inhibitor-1 during Cigarette Smoke Exposure Injury
Shwetha K. Shetty et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
The role of all-trans retinoic acid in bleomycin-induced pulmonary fibrosis in mice
Zhaoxing Dong et al.
EXPERIMENTAL LUNG RESEARCH (2012)
Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: Possible role of Th17 cells in chronic lung pathology
Neerad C. Mishra et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
RGS16 Attenuates Pulmonary Th2/Th17 Inflammatory Responses
Sucharita P. Shankar et al.
JOURNAL OF IMMUNOLOGY (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Tregs Promote the Differentiation of Th17 Cells in Silica-Induced Lung Fibrosis in Mice
Laiyu Song et al.
PLOS ONE (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunosuppressive Properties of Mesenchymal Stem Cells
Mohamed Abumaree et al.
STEM CELL REVIEWS AND REPORTS (2012)
How mesenchymal stem cells interact with tissue immune responses
Yufang Shi et al.
TRENDS IN IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Mesenchymal stromal cell 'licensing': a multistep process
M. Krampera
LEUKEMIA (2011)
Autophagy in immunity and inflammation
Beth Levine et al.
NATURE (2011)
Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent
Mark S. Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V
Ruedi K. Braun et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma Model
Ayumi Yoshizaki et al.
JOURNAL OF IMMUNOLOGY (2010)
CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis
Syed R. Gilani et al.
PLOS ONE (2010)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
Meghan A. Koch et al.
NATURE IMMUNOLOGY (2009)
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs
Xuexian O. Yang et al.
IMMUNITY (2008)
Autophagy: from phenomenology to molecular understanding in less than a decade
Daniel J. Klionsky
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis -: art. no. 81
Z Daniil et al.
RESPIRATORY RESEARCH (2005)
CD28 extinction in human T cells: altered functions and the program of T-cell senescence
AN Vallejo
IMMUNOLOGICAL REVIEWS (2005)
ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis
M Krasilnikov et al.
ONCOGENE (2003)